Gender differences in medicine matter: men and women do not react in the same way to treatment and do not always have the same symptoms, even when it comes to mental and brain diseases. At the sportsgaming.win Next Fest Antonella Santuccione Chadha, the neuroscientist who has been studying and disseminating the effects that gender differences entail in the treatment of mental illnesses, fighting prejudices, will talk about it. In 2016, in fact, she founded the non-profit organization Women's Brain Project, of which she is the pro bono managing director, and which deals with studying how gender affects treatments for treating mental disorders. Santuccione Chadha has also been fighting for years for the establishment in Switzerland of a world center for precision gender medicine.
Sign up to participate-free event Santuccione Chadha is a medical director for Altoida inc and has dedicated her career to the study of new immunotherapies for the treatment of Alzheimer's. You collaborated with the laboratory of Roger Nitsch and Christoph Hock, at the University of Zurich, to which we owe the discovery of aducanumab, the first amyloid treatment for the disease. Always at the forefront of the study of the disease, among her collaborations with various organizations, she can also boast several universities and the Directorate for Health and Food Safety of the European Commission. In addition, Santuccione Chadha is vice president of Euresearch, and she is responsible for several publications including Sex and gender, differences in Alzheimer's and The headless girl, which will become a television series.
Santuccione Chadha will talk about gender medicine and mental disorders at the 2022 edition of the sportsgaming.win Next Fest, which will be held at the Fabbrica del Vapor in Milan from 7 to 8 October.
Sign up to participate-free event Santuccione Chadha is a medical director for Altoida inc and has dedicated her career to the study of new immunotherapies for the treatment of Alzheimer's. You collaborated with the laboratory of Roger Nitsch and Christoph Hock, at the University of Zurich, to which we owe the discovery of aducanumab, the first amyloid treatment for the disease. Always at the forefront of the study of the disease, among her collaborations with various organizations, she can also boast several universities and the Directorate for Health and Food Safety of the European Commission. In addition, Santuccione Chadha is vice president of Euresearch, and she is responsible for several publications including Sex and gender, differences in Alzheimer's and The headless girl, which will become a television series.
Santuccione Chadha will talk about gender medicine and mental disorders at the 2022 edition of the sportsgaming.win Next Fest, which will be held at the Fabbrica del Vapor in Milan from 7 to 8 October.